发明名称 Humanized dipeptidyl peptidase IV (DPP4) animals
摘要 Non-human animals comprising a human or humanized DPP4 nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous Dpp4 gene with a human or humanized DPP4 gene, or non-human animals comprising a human or humanized DPP4 gene in addition to the endogenous Dpp4 gene are described. Non-human animals comprising a human or humanized DPP4 gene under control of human or non-human DPP4 regulatory elements is also provided, including non-human animals that have a replacement of non-human Dpp4-encoding sequence with human DPP4-encoding sequence at an endogenous non-human Dpp4 locus. Non-human animals comprising human or humanized DPP4 gene sequences, wherein the non-human animals are rodents, e.g., mice or rats, are provided. Methods for making and using the non-human animals are described.
申请公布号 US9497945(B2) 申请公布日期 2016.11.22
申请号 US201514723855 申请日期 2015.05.28
申请人 Regeneron Pharmaceuticals, Inc. 发明人 Kyratsous Christos;Mujica Alexander
分类号 A01K67/00;A01K67/027;C12Q1/70;C12Q1/68;G01N33/569 主分类号 A01K67/00
代理机构 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. 代理人 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
主权项 1. A rodent, comprising a humanization of an endogenous rodent Dpp4 gene, wherein the humanization comprises a replacement at the endogenous rodent Dpp4 locus of a rodent gene encoding an exon of an Dpp4 gene with a nucleic acid sequence encoding at least one exon of a human DPP4 gene to form a modified DPP4 gene, wherein expression of the modified DPP4 gene is under control of rodent regulatory elements at the endogenous rodent Dpp4 locus, wherein the rodent is a mouse or a rat, and wherein the rodent exhibits one or more symptoms when infected with Middle East respiratory syndrome coronavirus (MERS-CoV).
地址 Tarrytown NY US